The compound appears to help cells move to damaged areas and encourages the growth of new blood vessels, bringing nutrients and oxygen to tissues in need of repair
See more For the beta-2-agonist salmeterol administered by inhalation, the permitted dose* is a maximum of 200 micrograms over any 24-hour period
1 What's important to understand is that there are three distinct legal events the market keeps treating as one, removal from Category 2, a PCAC recommendation, and actual placement on the Category 1 compoundable list following notice-and-comment rulemaking
Under review simply means the FDA is still assessing: Safety Clinical relevance Regulatory appropriateness It does not mean: The peptide is approved The peptide is widely available The peptide is appropriate for general use At this stage, access to many of these substances may remain limited, inconsistent, or restricted, and quality can vary outside regulated pathways
Some researchers have asked whether combining cagrilintide (the amylin component of CagriSema) with tirzepatide (the GIP/GLP-1 dual agonist) could produce even greater results